Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**NSA2 pseudogene 6 (NSA2P6)** is a predicted pseudogene related to the functional NSA2 gene, which encodes a nucleolar protein involved in ribosome biogenesis and cell proliferation[1]. Pseudogenes like NSA2P6 are DNA sequences that resemble protein-coding genes but contain defects (such as frameshifts and stop codons) that prevent them from producing functional proteins[5][6][7]. While some pseudogenes participate in regulatory RNA mechanisms affecting their parent genes, there is no evidence that NSA2P6 has a functional role, is a therapeutic target, or is associated with any diseases or drugs. The existence and naming of "NSA2 pseudogene 6" indicate a non-functional, likely unstudied element of the genome, not a receptor, enzyme, or traditional molecular target.\n\n**Context and Explanation:**\n- **NSA2** is a protein-coding gene with clear biological functions in ribosome biogenesis and cell proliferation, and has several pseudogenes[1]. \n- **Pseudogenes** are generally considered nonfunctional genomic sequences, though some (not all) can act as regulatory RNAs or microRNA decoys under certain conditions[3][4].\n- No sources list “NSA2 pseudogene 6 (NSA2P6)” as a therapeutic or drug-targetable molecule, receptor, enzyme, transporter, or biomarker[1][2][3][4][5][6][7].\n- There is no evidence for interacting drugs or mechanisms of action related to this pseudogene.\n\n**Errors/Concerns:**\n- **is_incorrect = true**: “NSA2 pseudogene 6” is not a valid therapeutic target or receptor, nor does it refer to a functional or druggable protein, so it does not match the definition of a target molecule or receptor[5][6][7]. \n- Entries for drugs, biomarkers, safety, and detailed functions are left null due to the absence of evidence for NSA2P6 beyond its classification as a pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NSA2 pseudogene 6 (NSA2P6).